Physician profile
Karthikeyan Bhuvaneswaran
NPI 1164870499
$1,147.24
in general payments reported to CMS, 2019-2025
8 companies · $65.37 in 2025
The $65.37 reported for 2025 was less than what a typical Neuromuscular Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $128).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.73 · 2020: $15.28 · 2021: $748 · 2022: $173 · 2023: $25.73 · 2024: $59.86 · 2025: $65.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $624.67 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $123.65 | 2021 | |
| Amgen INC. | $119.40 | 2019-2022 | |
| Genentech USA, INC. | $80.28 | 2023-2025 | Evrysdi |
| Allergan, INC. | $77.71 | 2022 | |
| Genentech, INC. | $70.68 | 2024-2025 | Evrysdi |
| Medtronic USA, INC. | $33.59 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $17.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karthikeyan Bhuvaneswaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.